These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 26970773)

  • 1. Biomarkers in Scleroderma: Progressing from Association to Clinical Utility.
    Ligon C; Hummers LK
    Curr Rheumatol Rep; 2016 Mar; 18(3):17. PubMed ID: 26970773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localized scleroderma and systemic sclerosis: is there a connection?
    Gupta RA; Fiorentino D
    Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):1025-36. PubMed ID: 18068859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic sclerosis sine scleroderma: is it always the same disease? Report of three patients and discussion.
    Slobodin G; Rosner I; Rozenbaum M; Naschitz JE; Zuckerman E; Yeshurun D
    Rheumatol Int; 2002 Aug; 22(4):170-2. PubMed ID: 12172958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the diagnosis and treatment of interstitial lung disease in systemic sclerosis (scleroderma): a review.
    Tan A; Denton CP; Mikhailidis DP; Seifalian AM
    Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S66-74. PubMed ID: 21586221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for severity and manifestations in systemic sclerosis and prediction of disease course.
    Becker MO; Riemekasten G
    Expert Rev Clin Immunol; 2016; 12(2):115-35. PubMed ID: 26558747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging biomarkers in systemic sclerosis.
    Manetti M
    Curr Opin Rheumatol; 2016 Nov; 28(6):606-12. PubMed ID: 27380110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications.
    Ghizzoni C; Sebastiani M; Manfredi A; Campomori F; Colaci M; Giuggioli D; Ferri C
    Microvasc Res; 2015 May; 99():92-5. PubMed ID: 25842153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment.
    Affandi AJ; Radstake TR; Marut W
    Semin Immunopathol; 2015 Sep; 37(5):475-87. PubMed ID: 26168983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis and management of scleroderma and scleroderma-like disorders in children.
    Black CM
    Clin Exp Rheumatol; 1994; 12 Suppl 10():S75-81. PubMed ID: 7955633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentations and treatment of childhood scleroderma: localized scleroderma, eosinophilic fasciitis, systemic sclerosis, and graft-versus-host disease.
    Hedrich CM; Fiebig B; Hahn G; Suttorp M; Gahr M
    Clin Pediatr (Phila); 2011 Jul; 50(7):604-14. PubMed ID: 21525084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial lung disease in scleroderma.
    Schoenfeld SR; Castelino FV
    Rheum Dis Clin North Am; 2015 May; 41(2):237-48. PubMed ID: 25836640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Juvenile scleroderma].
    de Mâcedo PA; Shinjo SK; Goldenstein-Schainberg C
    Acta Reumatol Port; 2008; 33(3):289-97. PubMed ID: 18846006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers in the management of scleroderma: an update.
    Abignano G; Buch M; Emery P; Del Galdo F
    Curr Rheumatol Rep; 2011 Feb; 13(1):4-12. PubMed ID: 21046295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of systemic sclerosis biomarkers: applications for diagnosis, management and drug development.
    Castelino FV; Varga J
    Expert Rev Clin Immunol; 2013 Nov; 9(11):1077-90. PubMed ID: 24168414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localized and systemic scleroderma.
    Hawk A; English JC
    Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interstitial lung diseases in collagen vascular diseases.
    Lamblin C; Bergoin C; Saelens T; Wallaert B
    Eur Respir J Suppl; 2001 Sep; 32():69s-80s. PubMed ID: 11816826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scleroderma: nomenclature, etiology, pathogenesis, prognosis, and treatments: facts and controversies.
    Fett N
    Clin Dermatol; 2013; 31(4):432-437. PubMed ID: 23806160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential diagnosis of scleroderma and pseudoscleroderma.
    Fabri M; Hunzelmann N
    J Dtsch Dermatol Ges; 2007 Nov; 5(11):977-84. PubMed ID: 17976138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histochemical investigations in scleroderma (author's transl)].
    Kreysel HW; Brügge P; Jänner M; Kimmig J
    MMW Munch Med Wochenschr; 1976 Sep; 118(39):1235-40. PubMed ID: 135207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Scleroderma. Its various forms].
    Escande JP
    Nouv Presse Med; 1974 Mar; 3(9):537-8. PubMed ID: 4822162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.